Keov, P., Valant, C., Devine, S. M., Lane, J. R., Scammells, P. J., Sexton, P. M., & Christopoulos, A. (2013). Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor. Molecular Pharmacology, 84(3), 425-437. https://doi.org/10.1124/mol.113.087320